2023
DOI: 10.3892/or.2023.8606
|View full text |Cite
|
Sign up to set email alerts
|

Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…Girdin is an actin-binding protein, that is involved in cancer invasion and angiogenesis, and is a prognostic biomarker. Girdin can participate in pancreatic cancer (PaCa) migration mediated by EGF signal, and SCU can inhibit cancer invasion by inhibiting Girdin, thus playing a role in anti-cancer [ 62 ]. Li et al used an aminoethyl anisamide-targeted copolymerization approach to amplify the delivery capacity of scutellarin to facilitate the in vivo application of scutellarin in hepatocellular carcinoma (HCC) immunotherapy and demonstrated that scutellarin has the potential to trigger immunogenic cell death (ICD) in hepatocellular carcinoma HCC [ 63 ] ).…”
Section: Pharmacological Effectsmentioning
confidence: 99%
“…Girdin is an actin-binding protein, that is involved in cancer invasion and angiogenesis, and is a prognostic biomarker. Girdin can participate in pancreatic cancer (PaCa) migration mediated by EGF signal, and SCU can inhibit cancer invasion by inhibiting Girdin, thus playing a role in anti-cancer [ 62 ]. Li et al used an aminoethyl anisamide-targeted copolymerization approach to amplify the delivery capacity of scutellarin to facilitate the in vivo application of scutellarin in hepatocellular carcinoma (HCC) immunotherapy and demonstrated that scutellarin has the potential to trigger immunogenic cell death (ICD) in hepatocellular carcinoma HCC [ 63 ] ).…”
Section: Pharmacological Effectsmentioning
confidence: 99%